The Cause | Immunotherapy
The 2026 Toast of the Town Will Help Bring Life-Saving Cancer Treatment Home
Right now, CAR T-cell immunotherapy is one of the most promising cancer treatments available, but it requires Alberta patients to have their cells sent out of province for processing. It’s costly, slow, and limits access.
With your help, the Cure Cancer Foundation is raising $2.5 million by fall of 2026 to purchase the critical equipment needed to bring this therapy home to the Cross Cancer Institute. This state-of-the-art technology will allow scientists and clinicians to create personalized, cancer-fighting immune cells right here in Edmonton. This treatment will be faster, safer, and at a fraction of the current cost.
Your support isn’t just funding equipment.
It’s fueling possibility. It’s accelerating hope. It’s helping cure cancer—one cell, one patient, one discovery at a time.
Your donation will help fund:
- 4 CliniMACS Prodigy units to manufacture CAR T-cells for treatment and research
- MACSQuant Analyzer for quality control and analysis of the modified cells
- QuantStudio 12K Flex for working with DNA and building cell therapies
- xCELLigence eSight Platform to test multiple treatment prototypes simultaneously, speeding up research and saving lives
The response rate of Car T-cell therapies is 80%
More patients treated:
current systems only
treat one patient per
month. Your support will
enable us to treat at
least 12 patients a
month.
Existing commercial and
cellular therapy product
costs are high. In-house
manufacturing reduces
the cost of each
treatment by 90%.
We have an opportunity
to treat approximately
120 patients every year
that wouldn’t otherwise
have access to this
treatment.
